2型糖尿病与抑郁症双向关系的孟德尔随机化研究证据
该研究利用孟德尔随机化方法,在GWAS汇总数据和UK Biobank个体数据中评估重性抑郁障碍(MDD)与2型糖尿病(T2D)的双向因果关系。结果显示MDD遗传易感性翻倍与T2D风险升高相关(OR 1.14),T2D遗传易感性翻倍与MDD风险轻度升高相关(OR 1.02),且T2D对难治性抑郁(TRD)有预测作用。
要点
- MDD遗传易感性翻倍与T2D风险升高相关(OR 1.14,95%CI 1.09-1.19)。
- T2D遗传易感性翻倍与MDD风险轻度升高相关(OR 1.02,95%CI 1.01-1.03)。
- T2D可能预测难治性抑郁,且BMI多变量MR减弱双向关系。
核心结论
- MDD与T2D之间存在双向因果关联,MDD较强预测胰岛素抵抗和T2D,T2D预测MDD和TRD。
研究设计与样本
- 采用孟德尔随机化(MR)分析GWAS汇总统计数据和UK Biobank个体水平数据。
- 评估MDD与T2D、MDD与非糖尿病人群血糖生物标志物(如TG:HDL-C比值、空腹血糖)的双向因果关联。
- 在UK Biobank中检验T2D对难治性抑郁(TRD)的作用,并使用多变量MR(MVMR)评估BMI的作用。
主要发现
- MDD遗传易感性翻倍与T2D风险升高相关(OR 1.14,95%CI 1.09-1.19)。
- T2D遗传易感性翻倍与MDD风险轻度升高相关(OR 1.02,95%CI 1.01-1.03)。
- 按性别分层UKB中效应估计一致,并提示T2D对TRD有作用。
- T2D GWAS遗传变异聚类显示体脂途径(OR 1.04,95%CI 1.02-1.06)、肥胖介导的胰岛素抵抗途径(OR 1.06,95%CI 1.04-1.09)和残余血糖途径(OR 1.02,95%CI 1.00-1.04)在MDD关系中重要。
- MDD遗传易感性与非T2D个体较高TG:HDL-C比值相关(β 0.11,95%CI 0.08-0.14)。
关键数值与推荐
- MDD遗传易感性翻倍对应T2D风险OR 1.14(95%CI 1.09-1.19)。
- T2D遗传易感性翻倍对应MDD风险OR 1.02(95%CI 1.01-1.03)。
- 体脂途径变异OR 1.04(95%CI 1.02-1.06),肥胖介导胰岛素抵抗途径OR 1.06(95%CI 1.04-1.09),残余血糖途径OR 1.02(95%CI 1.00-1.04)。
- MDD遗传易感性与非T2D个体TG:HDL-C比值β 0.11(95%CI 0.08-0.14)。
临床怎么用
- 对MDD患者应关注胰岛素抵抗和T2D风险,监测血糖和TG:HDL-C比值。
- 对T2D患者应筛查抑郁症状,尤其难治性抑郁需考虑T2D的潜在影响。
- BMI等肥胖指标在多变量MR中减弱双向关系,提示体重管理可能影响MDD与T2D的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Major depressive disorder (MDD) and type 2 diabetes (T2D) represent two global health challenges with a high degree of co-occurrence. Here, we aim to investigate the causal relationship between MDD and T2D in diverse ancestries using Mendelian randomization (MR) in GWAS summary statistic and individual level (UK Biobank (UKB)) data. We assessed the bi-directional causal relationship between: (a) MDD and T2D and (b) MDD and glycaemic biomarkers (e.g. TG:HDL-C ratio, a measure of insulin resistance, fasting glucose) in non-diabetic individuals. In UKB we also tested the role of T2D on treatment resistant depression (TRD). We used multivariable MR (MVMR) to assess the role of body mass index (BMI) in the MDD to T2D relationship. Our results demonstrated that a doubling in MDD genetic liability was associated with 1.14 higher odds of T2D (95% CI:1.09, 1.19), whilst a doubling in T2D genetic liability associated with 1.02 higher odds of MDD (95% CI:1.01, 1.03). Consistent effect estimates were observed in the UKB when stratifying by sex and suggested a role for T2D in TRD. T2D GWAS derived clusters of genetic variants highlighted the importance of specific pathways in the MDD relationship, including variants raising T2D risk via body fat (OR:1.04; 95% CI:1.02, 1.06), obesity mediated insulin resistance (OR:1.06; 95% CI:1.04, 1.09) and residual glycaemic (OR: 1.02; 95% CI:1.00, 1.04) pathways. MVMR with BMI attenuated the bidirectional relationship between MDD and T2D, particularly from MDD to T2D. Genetic liability to MDD was also associated with higher TG:HDL-C ratio in individuals without T2D (β:0.11; 95% CI:0.08, 0.14). We provide evidence of bidirectional causal association between MDD and T2D, with MDD strongly predicting insulin resistance and T2D. T2D predicted both MDD and TRD and highlighted the importance of obesity and body fat pathways in the T2D to MDD relationship.
引用
- Bala R, Handley D, Gillett A, et al. Evidence of bidirectional relationship between type 2 diabetes and depression; a Mendelian randomization study. Mol Psychiatry. 2025. PMID: 40595333. doi:10.1038/s41380-025-03083-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。